Abstract
Purpose
Sarcoidosis is a multisystem disease that can negatively impact health-related quality of life (HRQL) across generic (e.g., physical, social and emotional wellbeing) and disease-specific (e.g., pulmonary, ocular, dermatologic) domains. Measurement of HRQL in sarcoidosis has largely relied on generic patient-reported outcome tools, with little disease-specific measures available. The purpose of this paper is to present the development and testing of disease-specific item banks and short forms of lung, skin and eye problems, which are a part of a new patient-reported outcome (PRO) instrument called the sarcoidosis assessment tool.
Methods
After prioritizing and selecting the most important disease-specific domains, we wrote new items to reflect disease-specific problems by drawing from patient focus group and clinician expert survey data that were used to create our conceptual model of HRQL in sarcoidosis. Item pools underwent cognitive interviews by sarcoidosis patients (n = 13), and minor modifications were made. These items were administered in a multi-site study (n = 300) to obtain item calibrations and create calibrated short forms using item response theory (IRT) approaches.
Results
From the available item pools, we created four new item banks and short forms: (1) skin problems, (2) skin stigma, (3) lung problems, and (4) eye Problems. We also created and tested supplemental forms of the most common constitutional symptoms and negative effects of corticosteroids.
Conclusions
Several new sarcoidosis-specific PROs were developed and tested using IRT approaches. These new measures can advance more precise and targeted HRQL assessment in sarcoidosis clinical trials and clinical practice.
Similar content being viewed by others
References
Michielsen, H. J., Drent, M., Peros-Golubicic, T., & De Vries, J. (2006). Fatigue is associated with quality of life in sarcoidosis patients. Chest, 130(4), 989–994.
De Vries, J., & Drent, M. (2007). Quality of life and health status in sarcoidosis: A review. Seminars in Respiratory and Critical Care Medicine, 28(1), 121–127.
Michielsen, H. J., Peros-Golubicic, T., Drent, M., & De Vries, J. (2007). Relationship between symptoms and quality of life in a sarcoidosis population. Respiration, 74(4), 401–405.
Milman, N., Svendsen, C. B., & Hoffmann, A. L. (2009). Health-related quality of life in adult survivors of childhood sarcoidosis. Respiratory Medicine, 103(6), 913–918.
De Vries, J., Lower, E. E., & Drent, M. (2010). Quality of life in sarcoidosis: Assessment and management. Seminars in Respiratory and Critical Care Medicine, 31(4), 485–493.
Saligan, L. N., Levy-Clarke, G., Wu, T., Faia, L. J., Wroblewski, K., Yeh, S., et al. (2010). Quality of life in sarcoidosis: Comparing the impact of ocular and non-ocular involvement of the disease. Ophthalmic Epidemiology, 17(4), 217–224.
Victorson, D. E., Cella, D., & Judson, M. A. (2008). Quality of life evaluation in sarcoidosis: Current status and future directions. Current Opinion in Pulmonary Medicine, 14(5), 470–477.
Judson, M. A. (2012). The treatment of pulmonary sarcoidosis. Respiratory Medicine, 106(10), 1351–1361.
Victorson, D. E., Cella, D., Grund, H., & Judson, MA. (2013). A conceptual model of health related quality of life in sarcoidosis. Quality of Life Research (Epub ahead of print).
Bourbonnais, J. M., Malaisamy, S., Dalal, B. D., Samarakoon, P. C., Parikh, S. R., & Samavati, L. (2012). Distance saturation product predicts health-related quality of life among sarcoidosis patients. Health Quality of Life Outcomes, 10, 67.
Drent, M., Wirnsberger, R. M., Breteler, M. H., Kock, L. M., de Vries, J., & Wouters, E. F. (1998). Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 15(1), 59–66.
De Vries, J., Michielsen, H., van Heck, G. L., & Drent, M. (2004). Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS). British Journal of Health Psychology, 9(Pt 3), 279–291.
Chang, J. A., Curtis, J. R., Patrick, D. L., & Raghu, G. (1999). Assessment of health-related quality of life in patients with interstitial lung disease. Chest, 116(5), 1175–1182.
Cox, C. E., Donohue, J. F., Brown, C. D., Kataria, Y. P., & Judson, M. A. (2004). Health-related quality of life of persons with sarcoidosis. Chest, 125(3), 997–1004.
de Kleijn, W. P., Drent, M., & De Vries, J. (2012). Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis. British Journal of Health Psychology, 18(2), 439–452.
Cox, C. E., Donohue, J. F., Brown, C. D., Kataria, Y. P., & Judson, M. A. (2003). The Sarcoidosis Health Questionnaire: A new measure of health-related quality of life. American Journal of Respiratory and Critical Care Medicine, 168(3), 323–329.
Patel, A. S., Siegert, R. J., Creamer, D., Larkin, G., Maher, T. M., Renzoni, E. A., et al. (2013). The development and validation of the King’s Sarcoidosis Questionnaire for the assessment of health status. Thorax, 68(1), 57–65.
Choppin, B. (1979). Testing the questions: The Rasch model and item banking. In MESA research memorandum No. 49. Chicago: University of Chicago, MESA Psychometric Laboratory.
Hays, R. D., Morales, L. S., & Reise, S. P. (2000). Item response theory and health outcomes measurement in the 21st century. Medical Care, 38(9 Suppl II), 28–42.
Carle, A. C., Cella, D., Cai, L., Choi, S. W., Crane, P. K., Curtis, S. M., et al. (2011). Advancing PROMIS’s methodology: Results of the third patient-reported outcomes measurement information system (PROMIS((R))) psychometric summit. Expert Review of Pharmacoeconomics & Outcomes Research, 11(6), 677–684.
Cella, D., Chang, C.-H., & Heinemann, A. W. (2002). Item response theory (IRT): Applications in quality of life measurement, analysis, and interpretation. In M. Mesbah, B. Cole, & M.-L. T. Lee (Eds.), Statistical methods for quality of life studies: Design, measurements, and analysis (pp. 169–186). Boston, MA: Kluwer.
Reeve, B. B., Chang, C. H., & Perfetto, E. (2007). Applying item response theory to enhance health outcomes assessment. Quality of Life Research, 16, 1–3.
Hays, R. D., & Lipscomb, J. (2007). Next steps for use of item response theory in the assessment of health outcomes. Quality of Life Research, 16, 195–199.
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.
Lawson, D. M. (2011). PROMIS: A new tool for the clinician scientist. The Journal of the Canadian Chiropractic Association, 55(1), 16–19.
Ader, D. N. (2007). Developing the patient-reported outcomes measurement information system (PROMIS). Medical Care, 45(5 Suppl 1), S1–S2.
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.
Rose, M., Bjorner, J. B., Becker, J., Fries, J. F., & Ware, J. E. (2008). Evaluation of a preliminary physical function item bank supported the expected advantages of the patient-reported outcomes measurement information system (PROMIS). Journal of Clinical Epidemiology, 61(1), 17–33.
Hahn, E. A., Devellis, R. F., Bode, R. K., Garcia, S. F., Castel, L. D., Eisen, S. V., Bosworth, H. B., Heinemann, A. W., Rothrock, N., Cella, D., & Group, P. C. (2010). Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Quality of Life Research, 19(7), 1035–1044.
Junghaenel, D. U., Christodoulou, C., Lai, J. S., & Stone, A. A. (2011). Demographic correlates of fatigue in the US general population: Results from the patient-reported outcomes measurement information system (PROMIS) initiative. Journal of Psychosomatic Research, 71(3), 117–123.
Kim, J., Chung, H., Amtmann, D., Revicki, D. A., & Cook, K. F. (2012). Measurement invariance of the PROMIS pain interference item bank across community and clinical samples. Quality of Life Research, 22(3), 501–507.
Buysse, D. J., Yu, L., Moul, D. E., Germain, A., Stover, A., Dodds, N. E., et al. (2010). Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep, 33(6), 781–792.
Riley, W. T., Pilkonis, P., & Cella, D. (2011). Application of the national institutes of health patient-reported outcome measurement information system (PROMIS) to mental health research. The Journal of Mental Health Policy and Economics, 14(4), 201–208.
DeWalt, D. A., Rothrock, N., Yount, S., & Stone, A. A. (2007). Evaluation of item candidates: The PROMIS qualitative item review. Medical Care, 45(5 Suppl 1), S12–S21.
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., et al. (2007). The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH roadmap cooperative group during its first two years. Medical Care, 45(5 Suppl 1), S3–S11.
Webster, K., Odom, L., Peterman, A. H., Lent, L., & Cella, D. (1999). The functional assessment of chronic illness therapy (FACIT) measurement system: Validation of version 4 the core questionnaire. Quality of Life Research, 8(7), 604(#216)–604.
Willis, G. B. (2005). Cognitive interviewing: A tool for improving questionnaire design. Thousand Oaks, CA: Sage.
Christodoulou, C., Junghaenel, D. U., DeWalt, D. A., Rothrock, N., & Stone, A. A. (2008). Cognitive interviewing in the evaluation of fatigue items: Results from the patient-reported outcomes measurement information system (PROMIS). Quality of Life Research, 17(10), 1239–1246.
Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J.-S., et al. (2010). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, 92(10 Suppl), S28–S36.
Tulsky, D. S., Kisala, P. A., Victorson, D., Tate, D., Heinemann, A. W., Amtmann, D., et al. (2011). Developing a contemporary patient-reported outcomes measure for spinal cord injury. Archives of Physical Medicine and Rehabilitation, 92(10 Suppl), S44–S51.
Judson, M. A. (1999). An approach to the treatment of pulmonary sarcoidosis with corticosteroids: The six phases of treatment. Chest, 115(4), 1158–1165.
Muthen, L. K., & Muthen, B. O. (2006). Mplus user’s guide (4th ed.). Los Angeles, CA: Muthen & Muthen.
Samejima, F. (1969). Estimation of ability using a response pattern of graded scores. Richmond, VA: Psychometric Society.
Miles, J., & Shevlin, M. (2007). A time and a place for incremental fit indices. Personality and Individual Differences, 42, 869–874.
Hunninghake, G. W., Costabel, U., Ando, M., Baughman, R., Cordier, J. F., Du, B. R., et al. (1999). ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/European respiratory society/world association of sarcoidosis and other granulomatous disorders. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 16(2), 149–173.
Rybicki, B. A., & Iannuzzi, M. C. (2007). Epidemiology of sarcoidosis: Recent advances and future prospects. Seminars in Respiratory and Critical Care Medicine, 28(1), 22–35.
Acknowledgments
This research was supported by J & J Pharmaceutical Services.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Victorson, D.E., Choi, S., Judson, M.A. et al. Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis. Qual Life Res 23, 1301–1313 (2014). https://doi.org/10.1007/s11136-013-0567-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0567-6